Georgia Kolliopoulou

Georgia Kolliopoulou

Auto-generated profile, based on publicly available information

Georgia Kolliopoulou

Department of Anesthesiology, Patras University Hospital, Patras, Greece

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2017 in Hematology
Verified
Journal Article
Closed access
CAChristina Avgerinou
Christina Avgerinou
IGIoanna Giannezi
Ioanna Giannezi
STStela Theodoropoulou
Stela Theodoropoulou
VLVasileios Lazaris
Vasileios Lazaris
GKGeorgia Kolliopoulou
Georgia Kolliopoulou
Argiris SymeonidisArgiris Symeonidis
Argiris Symeonidis
Purpose: We have observed an increasing incidence of myelodysplastic syndromes (MDS) in the geographic area of Western Greece during the past two decades. The objective of this study was to investigate potential risk factors for the manifestation of MDS in this area of Greece. Methods: A hospital-based case–control study was conducted in the public hospitals of the region. Participants were interviewed based on a questionnaire regarding demographics, occupational exposures, smoking, alcohol consumption, dietary, and domestic factors. Results: A total of 228 individuals (126 cases, 102 controls) were recruited in this study. Univariate analysis showed that risk of MDS was associated with a family history of hematologic malignancy or solid tumor, exposure to pesticides, insecticides, herbicides, increased weekly intake of meat and eggs, and increased alcohol intake, whereas fruit intake had a protective effect. Analysis by pesticide ingredient showed a weak association of exposure to paraquat and glyphosate with the occurrence of MDS. Multivariate analysis showed that independent risk factors for the manifestation of MDS were family history of solid tumor (OR 2.47, 95% CI 1.32–4.65), meat intake for ≥5 days/week (OR 2.67, 95% CI 1.05–6.80) and exposure to pesticides (OR 3.25, 95% CI 1.73–6.11). Conclusions: Exposure to pesticides is a major risk factor of MDS in Western Greece. Family history of solid tumor and increased meat intake also appear to play a role in the pathogenesis of MDS. Public health authorities should implement policies to advise and protect farmers from the harmful effects of agrochemicals. Emphasis should also be given to health promotion advice including healthy eating.

9 December 2015 in Cardiovascular & Hematological Disorders-Drug Targets
Verified
Journal Article
Closed access
EVEvgenia Verigou
Evgenia Verigou
PLPolixeni Lampropoulou
Polixeni Lampropoulou
NSNikoletta Smyrni
Nikoletta Smyrni
GKGeorgia Kolliopoulou
Georgia Kolliopoulou
GSGeorge Sakellaropoulos
George Sakellaropoulos
MKMarina Karakantza
Marina Karakantza
Myelodysplastic Syndromes (MDS) are a group of clonal hematopoietic stem cell disorders with significant heterogeneity in their clinical presentation and the prognosis of the patients. Several attempts have been made to incorporate flow cytometry (FC) findings into the diagnostic and/or prognostic criteria of dysplasia, but bone marrow (BM) aspirate morphology evaluation remains the gold-standard for diagnosis. The purpose of this study was to provide a diagnostic tool for MDS that relies on BM immunophenotyping and objectifies the interpretation of FC analysis and to validate its capacity to discriminate MDS from other causes of cytopenias. To that purpose, a mathematical formula was developed which incorporates granulocytic maturation markers and the percentage of selected myeloid populations and translates them into a single parameter that quantifies the maturation and differentiation defects of BM granulocytes, named Dysmyelopoiesis Index (DMI). Bone marrow samples from 84 MDS patients and 47 non-MDS cytopenic patients were analyzed with FC and DMI was calculated for every patient. DMI detected clonal dysplasia with 84.5% sensitivity and 93.6% specificity, identified as MDS 77.2% of low grade patients and revealed multilineage dysplasia for a number of RA and RARS cases. It discriminated prognostic subgroups of MDS patients (P< .005) and negatively correlated with IPSS (r= - .472, P= .000), WPSS (r= - .481, P= .000) and IPSS-R (r= -.395, P= .000). DMI represents an accurate quantification of dysmyelopoiesis and an effective stand-alone diagnostic test for MDS, facilitating FC analysis and daily clinical practice.

20 November 2020 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
PDF file
Konstantinos G MoulakakisKonstantinos G Moulakakis
Konstantinos G Moulakakis
SPSpyros Papadoulas
Spyros Papadoulas
GKGeorgia Kolliopoulou
Georgia Kolliopoulou
AGAndreas Georgiakakis
Andreas Georgiakakis
PTPolyzois Tsantrizos
Polyzois Tsantrizos
KKKonstantinos Katsanos
Konstantinos Katsanos